focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.90
Bid: 3.30
Ask: 4.50
Change: -0.10 (-2.50%)
Spread: 1.20 (36.364%)
Open: 4.00
High: 0.00
Low: 0.00
Prev. Close: 4.00
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proteome Appoints Geoffrey Ellis As Finance Director, Loss Widens

Tue, 30th Sep 2014 09:41

LONDON (Alliance News) - Proteome Sciences PLC said Tuesday that has appointed Geoffrey Ellis as Finance Director, and posted a slightly widened pretax loss for the half-year to the end of June.

Ellis previously acted as chief financial officer of The Walt Disney Co's Network of Disney Channels in Europe, the Middle East and Africa, and managing director Disney Channel Scandinavia, Middle East and Emerging Markets.

Ellis succeeds James Malthouse, who is retiring after 20 years with the company.

Proteome posted a pretax loss of GBP2.1 million, widened from a loss of GBP1.9 million a year before, as revenue declined to GBP784,276 from GBP885,475, and administrative expenses rose slightly to GBP2.5 million from GBP2.3 million.

The company said following the growth in licensing, services and sales of its Tandem Mass Tag reagents in 2013, its core technologies had continued to strengthen in the first-half of 2014. Some contracts it was expecting were delayed, however, and the company said because of their size it is difficult to predict when they will come through.

Proteome said that whilst it is "difficult to be precise" over the timing of these revenue contributions, the scale and number of contracts in its order book is "growing steady and that performance is expected to continue in 2015."

Sales of Tandem Mass Tag reagent's rose 98% compared to the previous year. Proteome expects to see a more significant contribution from the products in the second-half, as well as continued improvement in its revenues from licences, sales and services.

Last Friday the company announced "excellent" results from in vitro toxicity tests for its two lead compounds to treat Alzheimer's disease, which it hopes will attract pharmaceutical companies to partner with Proteome on the treatments.

Shares in Proteome are trading down 8.0% at 35.18 pence Tuesday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2019 11:20

Proteome Sciences Annual Loss Narrows But Misses Expectations

LONDON (Alliance News) - Proteome Sciences PLC on Tuesday reported a narrowed annual loss, lagging behind the company's expectations.Proteome Sciences shares were trading down 18% at a

Read more
23 Jan 2019 11:14

Proteome Sciences Expects Narrowed Annual Loss On Lower Expenses

LONDON (Alliance News) - Proteome Sciences PLC on Wednesday said it expects to post a narrowed loss for 2018 due to an ongoing cost savings programme and despite revenue taking a hit from weak in

Read more
23 Nov 2018 13:50

DIRECTOR DEALINGS: Proteome Sciences Non-Exec Director Buys Shares

LONDON (Alliance News) - Proteome Sciences PLC on Friday said Non-Executive Director Martin Diggle purchased shares in the biomarker research company following a transaction on acquired 500,000 at

Read more
6 Nov 2018 10:43

WINNERS & LOSERS SUMMARY: IWG Rises After Strong Third Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Associated up

Read more
6 Nov 2018 09:46

Proteome Sciences Shares Hit As It Expects Operating Loss Like In 2017

LONDON (Alliance News) - Proteome Sciences PLC said Tuesday it expects an operating loss "similar to 2017" in 2018, as the firm's overall performance remains behind shares were down

Read more
12 Sep 2018 17:37

DIRECTOR DEALINGS: Proteome Non-Executive Director Buys Shares

LONDON (Alliance News) - Drug development company Proteome Sciences PLC said Non-Executive Director Martin Diggle purchased 601,582 shares at a price of 3.60 pence per share on this GBP21,657 now

Read more
7 Sep 2018 16:40

DIRECTOR DEALINGS: Proteome Sciences Non-Exec Director Buys Shares

LONDON (Alliance News) - Biopharmaceutical research firm Proteome Sciences PLC said Friday Non-Executive Director Martin Diggle purchased 469,866 shares at a price of 3.60 pence each on acquired a

Read more
14 Aug 2018 17:58

DIRECTOR DEALINGS: Proteome Sciences non-Exec Director Acquires Shares

LONDON (Alliance News) - Proteome Sciences PLC on Tuesday said Non-Executive Director Martin Diggle purchased shares in the science research company.In a transaction on Monday, Diggle at a

Read more
9 Aug 2018 14:50

DIRECTOR DEALINGS: Fund Linked To Proteome Director Buys Shares

LONDON (Alliance News) - Proteome Sciences said Thursday that Vulpes Life Sciences Fund purchased 1.4 million shares in the company on Tuesday at 3.50 pence each.Vulpes now has a 19.6% in a

Read more
2 Aug 2018 18:15

DIRECTOR DEALINGS: Proteome Non-Exec Director's Fund Buys Shares

LONDON (Alliance News) - Proteome Science PLC said Thursday that Vulpes Life Sciences Fund, a firm related to a non-executive director Martin Diggle, has bought shares in the company.Diggle

Read more
31 Jul 2018 17:45

DIRECTOR DEALINGS: Fund Linked To Proteome Non-Exec Buys Shares

LONDON (Alliance News) - Proteome Sciences PLC said on Tuesday Vulpes Life Sciences Fund bought shares in the company on Friday.Proteome Non-Executive Martin Diggle is also a director of at

Read more
27 Jul 2018 12:52

Vulpes Buys Proteome Sciences Shares, Raising Joint Director Interest (ALLISS)

LONDON (Alliance News) - Pharmeceutical company Proteome Sciences PLC said Friday that Vulpes Life Sciences Fund purchased 171,000 shares at a price of 2.85 pence per share on in Proteome were up

Read more
24 Jul 2018 10:45

Proteome Shares Drop On Half-Year Performance Behind Expectations

LONDON (Alliance News) - Shares in Proteome Sciences PLC tumbled on Tuesday as the company reported half-year performance "behind expectations".Shares were trading down 11% at for

Read more
24 Jul 2018 08:04

Proteome punished as sales fail to perk up

(Sharecast News) - Proteome Sciences trimmed losses in the first half as the protein biomarker specialist cut costs and revenues stalled.

Read more
30 May 2018 14:58

Proteome Sciences Meeting Expectations Despite Slow First Quarter

LONDON (Alliance News) - Proteome Sciences PLC Chief Executive Officer Jeremy Haigh said Wednesday at the company's annual general meeting trading in the year-to-date has been in line despite

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.